Equitable Trust CO Astrazeneca PLC Transaction History

Equitable Trust CO

$1.72 Billion
Q4 2024

A detailed history of Equitable Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Equitable Trust CO holds 56,044 shares of AZN stock, worth $3.99 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

56,044

Previous 56,986 1.65%

Holding current value

$3.99 Million

Previous $4.44 Million 17.3%

% of portfolio

0.21%

Previous 0.3%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$63.2 - $79.58 $59,534 - $74,964	-942 Reduced 1.65%	56,044 $3.67 Million
Q3 2024 Nov 01, 2024	SELL	$76.67 - $87.62 $72,836 - $83,239	-950 Reduced 1.64%	56,986 $4.44 Million
Q2 2024 Aug 01, 2024	BUY	$66.81 - $80.83 $911,288 - $1.1 Million	13,640 Added 30.79%	57,936 $4.52 Million
Q1 2024 Apr 25, 2024	BUY	$61.03 - $69.57 $21,238 - $24,210	348 Added 0.79%	44,296 $3 Million
Q4 2023 Jan 25, 2024	SELL	$61.89 - $69.28 $167,907 - $187,956	-2,713 Reduced 5.81%	43,948 $2.96 Million
Q3 2023 Nov 07, 2023	SELL	$64.85 - $71.7 $61,542 - $68,043	-949 Reduced 1.99%	46,661 $3.16 Million
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $33,836 - $36,692	-484 Reduced 1.01%	47,610 $3.41 Million
Q1 2023 May 08, 2023	SELL	$63.15 - $71.6 $393,424 - $446,067	-6,230 Reduced 11.47%	48,094 $3.34 Million
Q4 2022 Feb 21, 2023	SELL	$54.21 - $70.44 $461,923 - $600,219	-8,521 Reduced 13.56%	54,324 $3.68 Million
Q3 2022 Nov 03, 2022	BUY	$53.02 - $135.75 $3.1 Million - $7.95 Million	58,546 Added 1361.85%	62,845 $3.45 Million
Q2 2021 Aug 03, 2021	SELL	$48.42 - $60.18 $48 - $60	-1 Reduced 0.02%	4,299 $258,000
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $202,787 - $234,092	4,300 New	4,300 $214,000

Others Institutions Holding AZN

# of Institutions

1,335

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account

Equitable Trust CO Astrazeneca PLC Transaction History